3-HMPPA Sympathetic Nerve Activation Composition for Food Use

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a strong demand for a novel material that has a sympathetic activation effect and is highly safe for use in food and drink products, pharmaceutical products, and research reagents, with 3-(4-hydroxy-3-methoxyphenyl) propionic acid (Structural Formula (1)) not previously recognized for such effects.

Innovation Solution

A sympathetic nerve activation agent and composition utilizing 3-(4-hydroxy-3-methoxyphenyl) propionic acid (Structural Formula (1)) to enhance sympathetic nerve activity in white adipose tissue, brown adipose tissue, adrenal glands, and liver, formulated into various dosage forms and compositions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a novel sympathetic activation material is developed for food and drink products, then safety and applicability are improved, but the lack of known effective compounds with proven safety limits creates uncertainty in selection

Engineering Contradiction:

ImprovesafetyVSAvoidapplicability

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical parameter by selecting 3-(4-hydroxy-3-methoxyphenyl) propionic acid (3-HMPPA) as the active compound, which is a metabolite of ferulic acid. This compound was chosen based on its demonstrated sympathetic activation effect and its safety profile as a natural metabolite, resolving the contradiction between needing a novel effective compound and ensuring safety for food applications.

Inventive Principle:

Principle #35Parameter changes

2Reliability

If existing sympathetic activation compounds are used, then activation effect is achieved, but their safety profile and suitability for food products remains uncertain or insufficient

Engineering Contradiction:

ImprovesafetyVSAvoidsympathetic activation effect

Core Design Contradiction:

ReliabilityVSPower

Solution Approach 1:

The patent uses 3-HMPPA as an intermediary substance that connects the natural compound ferulic acid to sympathetic activation effects. 3-HMPPA is a metabolite produced when lactic acid bacteria ferment ferulic acid, and it has been demonstrated to activate sympathetic nerves. This intermediary approach ensures safety since it is a natural metabolite while achieving the desired activation effect.

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentUS20250302783A1Sympathetic nerve activation agent and sympathetic nerve activation composition

Publication Date: 2025.10.02 MARUZEN PHARMA

AI summary

A sympathetic nerve activation agent includes a compound represented by Structural Formula (1).